CLINICAL_TRIALS
withdrawal
· 2014-03-27
Clinical Trial Update: Bumetanide Versus Furosemide in Heart Failure [Phase 3]
Summary
A Phase 3 trial comparing bumetanide to furosemide in heart failure has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Heart Failure | Phase 3 | Status: WITHDRAWN